This webinar will:
- Raise awareness of sex and gender dimensions in COVID-19 vaccines, and its considerations in policy decision-making, and science communication for the public.
- Describe lessons from past knowledge of sex-based differences in vaccine science and policy decision-making, including use of sex-disaggregated data and gender analysis in regulatory evaluations.
- Discuss current opportunities to respond to the biological differences in women and men in COVID-19 vaccine research and consequent deployment.
- Explore the path to ‘do better’ in addressing the sex and gender dimensions in vaccine and pharmaceutical R&D, policy-making and science communication process.
Webinar links will be sent to registered emails closer to the event.